REDWOOD CITY, Calif., Feb. 11, 2019 /PRNewswire/ -- Karius, a life sciences company, announced today that the peer-reviewed journal Nature Microbiology published a study validating the Karius® Test ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a leader in genomic diagnostics for infectious diseases, announced today that the Karius Test® has been granted designation as a Breakthrough ...

After picking up $100 million in venture capital cash earlier this month, Karius is adding another feather to its cap with a breakthrough designation from the FDA. The company’s DNA-based blood test ...

Identifying the cause of an infectious disease is time-consuming and not always easy. So a company called Karius has developed a blood test that analyzes cell-free DNA to identify more than a thousand ...

Many times, the first we realize we're getting sick is when symptoms show up. New science research is making it possible for people to discover they're getting sick before symptoms appear, allowing ...

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s upcoming sequel to its technology-focused venture capital megafund. Karius’ ...

REDWOOD CITY, Calif., Aug. 3, 2020 /PRNewswire/ -- Karius, the world leader in liquid biopsy for infectious diseases, announced today active enrollment in a multicenter, prospective study that will ...

Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, ...

The new partnership between Capstone Health Alliance and Karius provides more patients with access to the innovative the Karius Test® technology and helps improve the diagnosis of infections REDWOOD ...

Early last spring, as flu season hit its peak, a woman checked into a Houston hospital with all the familiar symptoms: fever, headache, a grating cough. A chest x-ray revealed an infection engulfing ...